Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Adapting Care for Pediatric Patients & Parents During the Pandemic: Q&A with Sangeeta Sule, MD, PhD

Susan Bernstein  |  May 1, 2020

Q: What are you telling patients or parents about the potential risks of COVID-19 or symptoms to watch for? What are their chief concerns, including access to care for medications?
From a parent’s or teenage patient’s point of view, the fact that they’re on immunosuppressant drugs to control their disease makes them scared right now. Parents are worried that if they go outside to run errands, such as a trip to the grocery store, they will bring disease back into their homes. There’s a lot of fear and uncertainty. What we have been telling people is that if your child has a fever, body aches, loss of taste or smell, cough, or any respiratory or gastrointestinal distress, call your doctor to discuss immediately.

Access to medications is also a concern. When all the press came out about hydroxychloroquine, we started getting a lot of calls from families that pharmacies were having shortages of the drug. Children with lupus could only get a one to two-week supply at a time. Another big worry is that this type of shortage could happen with biologics, such as tocilizumab and others being studied as possible COVID-19 treatments. Also, I had a parent tell me the alcohol swabs they use to clean the skin prior to weekly methotrexate injections was out of stock at many stores. We have been encouraging families to fill their prescriptions in a timely manner to avoid running out of medications.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Q: How are the pandemic and social distancing affecting you and your family personally?
During these times, all of us have to adjust to a new normal. I am planning my shopping in advance to reduce the number of outings. I am also doing more shopping online and conserving the supplies I have.


Susan Bernstein is a freelance journalist based in Atlanta.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 | Single Page
Share: 

Filed under:Conditions

Related Articles

    Pediatric Rheumatologist Shortage Spurs Need for Adult Specialists to Treat Children with Rheumatic Conditions

    February 15, 2017

    WASHINGTON, D.C.—Addressing a gathering of healthcare providers at the 2016 ACR/ARHP Annual Meeting concurrent session titled, Pediatric Rheumatology for the Adult Rheumatologist, part of the ACR Review Course, expert Sangeeta Sule, MD, PhD, associate professor of pediatrics specializing in rheumatology at Johns Hopkins Hospital in Baltimore, displayed a color-coded map of the U.S. on which…

    The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

    March 17, 2020

    In this time of COVID-19, you may be considering ways to deliver routine rheumatologic care via some form of telemedicine. Here are some of the legal considerations.

    Practicing Telemedicine Raises Legal Considerations for Rheumatologists

    July 12, 2016

    With the evolution and advancement of technology, it was only a matter of time before such changes affected the medical industry. Although the concept of telemedicine dates back more than 50 years, emphasis on cost-effective quality healthcare coupled with technological advancements has caused a resurgence of telemedicine in recent years. What constitutes telemedicine largely depends…

    Some Telemedicine Barriers Are Down During COVID-19 Pandemic

    May 15, 2020

    Telerheumatology—which refers to the application of electronic communication technology to clinical encounters from a distance between rheumatologists and their patients—has the potential to extend a workforce projected to experience significant shortfalls, making it more accessible to more patients. Multiple barriers that stood in the way of taking full advantage of this promise are now down—at…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences